|
MedKoo's special collection
Anticancer molecular libraries
Note: This webpage
will be completed in next few months, which
is being constructed mainly based on Dr. Qingqi Chen's new book entitled
"Anticancer Small Molecular Libraries"
ISBN: 9787030264473,
published by Science Press, Beijing,
China (Feb 2010).
Please visit this page shortly. Please inquire
any agents listed in our webpages.
Anti-androgen
agents
AKT
inhibitors
Anti-metastasis
agents (
migration inhibitors)
Anti-metabolite
agents
Aromatase
inhibitors
Aurora
kinase inhibitors
BCL-2
inhibitors (B-Cell lymphoma 2 inhibitors)
BCR-ABL inhibitors
Bioreductive agents
CA
inhibitors (carbonic anhydrase inhibitors)
Cancer stem
cell inhibitors
Cell cycle checkpoint inhibitors
CDK
inhibitors (Cyclin-dependent kinase inhibitors)
c-Kit inhibitors
c-Met
inhibitor
Cyclooxygenase inhibitors
DNA-cleaving agents
DNA-cross-linking
agents
DNA
intercalating agents
DNA-PK inhibitors
DNA-sequence targeting agents
DNA G-quadruplex
stabilizers
DNA
Monoalkylation agents
EGFR (HER)
inhibitors
Epigenetic-based therapeutic agents
Farnesyl transferase inhibitors
FLT3 inhibitors
(FMS-like tyrosine kinase 3 inhibitors)
HDAC
inhibitors (Histone deacetylase inhibitors)
HSP
inhibitors (heat shock protein inhibitors)
Hypoxia cytotoxic agents
IGF-IR
inhibitors (insulin-like growth factor I receptor inhibitors)
IMPDH
inhibitors (inosine 5'-monophosphate dehydrogenase inhibitors)
JAK
inhibitors ( Janus Kinase Inhibitors)
JNK
inhibitors (c-Jun N-trminal kinase inhibitors)
KSP
inhibitors (Kinesin spindle protein inhibitors)
LH-RH
related agents (luterinizing hormone-releasing hormone related agents)
LTB4 receptor
antagonists (Leukotriene B4 antagonists)
MEK
inhibitors
MGMT/AGT
inhibitors
Microtube
inhibitors
MMP
inhibitors (Matrix metalloproteinase inhibitors)
mTOR inhibitors (mammalian target of rapamycin inhibitors)
MGMT/AGT
inhibitors
Multiple kinase inhibitors
Platinum
anticancer agents
PARP
inhibitors (poly(adenosine diphosphate ribose) polymerase inhibitors)
P-glycoprotein
inhibitors (MDR resistance inhibitors)
Photodynamic
therapy drugs (PDT photosensitizers)
PI3K inhibitors (phosphoinisitide-3 kinase inhibitors)
PLK-1
inhibitors (Polo-like kinase inhibitors)
Proteasome
inhibitors
Radiosensitizing agents
SERMs
(selective estrogen-receptor modulators)
Somatostain-related anticancer agents
SPR
modulators (Selective progesterone receptor)
STAT3
inhibitors (signal transduction and activator of transcription
inhibitors)
STS
inhibitors (Steroid sulfatase inhibitors)
Supportive care
agents
Survivin inhibitors
Targeted
therapeutic agents
Telomerase
inhibitors
Thioredoxin reductase inhibitors
Topoisomerase
inhibitors
Vascular disrupting agents (VDAs)
VEGFR (PDGFR) inhibitors
|
